$RTX

Pentagon Awards Raytheon $6.3 Billion Missile Interceptor Contract

The Department of War awarded Raytheon, part of RTX Corporation, a $6.3 billion contract to produce SM-3 Blk IB missile interceptors over five years, with a two-year extension option. The deal aims to boost U.S. weapons production and replenish stockpiles. Raytheon plans to manufacture the interceptors in Alabama and Arizona, citing increased demand and depleted inventories from Middle East conflicts.

Original reporting
Published Oct 9, 2026, 8:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 10:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Pentagon Awards Raytheon $6.3 Billion Missile Interceptor Contract — source image
Decision brief

The 30-second read

$RTXBullishHigh
01

Why it matters

The award adds a sizable, recurring revenue stream for RTX's defense segment, likely supporting near‑term earnings guidance.

02

Market read

New defense contract is a material catalyst for RTX, potentially driving short‑term price appreciation.

03

What to watch

Potential cost overruns or competition from other defense firms could temper upside.

Relevance 7/10Novelty 9/10Timing: post‑market today

Background

The Pentagon announced a five‑year, up‑to‑$6.3 billion contract for SM‑3 Block IB missile interceptors, expanding Raytheon's production capacity.

Company-level read

Ticker impact

$RTXBullishHigh confidence
Context

Raytheon, part of RTX, received a new $6.3 billion Pentagon contract for SM‑3 Block IB interceptors.

Expected impact

likely upward pressure as investors price in higher defense revenue.

Evidence & confidence

Large, newly disclosed defense contract; historically moves defense stocks positively.

Market effects

Boosts defense sector earnings expectations and may lift related aerospace stocks.

Positive for U.S. defense manufacturers; limited regional effect.

Highlights continued U.S. defense spending, relevant for global defense supply chains.

Counterpoint

If the contract faces execution delays, the stock may not benefit as expected.

Key entities

  • Raytheon Technologies Corp.

    Defense contractor receiving the contract.

  • U.S. Department of Defense

    Awarding agency for the missile interceptor contract.

Related articles

$BAMed

Aerospace and defense stocks offer opportunity, Barclays says in launching coverage

Barclays launched coverage of 20 aerospace and defense companies, rating Boeing (BA) and RTX (RTX) Overweight. Analyst Anthony Valentini expects Boeing to return to normalized growth and RTX to benefit from new aircraft content and missile exposure. Other Overweight picks include Rocket Lab (RKLB), CAE (CAE), DPC (DDPC), Kratos (KTOS), Karman (KRMN), Archer Aviation (ACHR), Beta Technologies (BETA), SpaceX (SPCX), and Palantir (PLTR).

$RTXMed

$6.3 billion Pentagon deal buys more interceptors to shoot down ballistic missiles

Raytheon, an RTX business, received a $6.3 billion Pentagon contract for Standard Missile-3 Block IB interceptors. The deal includes $454 million in immediate funds for fiscal year 2026. Production will occur in Tucson, Arizona, and Huntsville, Alabama, supporting domestic defense vendors. The interceptors can be deployed from ship or land to defend against short- to intermediate-range ballistic missiles.

$RTXMed

RTX Keeps Winning Contracts, but Jim Cramer Sees a Complication

RTX Corporation (NYSE:RTX) reported Q2 sales of $24.7B, up 14%, and adjusted EPS of $1.89, up 21%. Its backlog reached $289B. Management raised its full-year adjusted EPS outlook to $7.10-$7.25. RTX secured a $20.7B missile production contract. Jim Cramer noted defense demand but concerns about commercial aviation and engine-related costs.

$RTXMed

RTX Initiates Coverage On Barclays -- Rating Set to Overweight

Barclays initiated coverage on RTX (Raytheon Technologies) with an 'Overweight' rating and a $223.00 price target. RTX is currently trading at $183.58, which is 18.2% overvalued according to its GF Value™ of $155.33. The company has a GF Score™ of 88/100, indicating strong overall performance. Insider activity shows significant selling, with $6.86 million in sales over the past three months.